Fennec Pharmaceuticals Inc. - Common Stock — Flux de trésorerie (NASDAQ:FENC) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -15.6 M-14.22 M-18.06 M-17.14 M26.98 M-12.47 M -5.78 M Flux de trésorerie liés aux activités d'investissement —————— — Flux de trésorerie liés aux activités de financement 32.29 M4.98 M20.73 M6.64 M-13.62 M22.63 M 23.28 M Flux de trésorerie disponible -15.6 M-14.22 M-18.06 M-17.14 M26.98 M-12.47 M -5.78 M

Nouvelles

Do Options Traders Know Something About Adherex Technologies Stock We Don't?

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

L’action Fennec Pharmaceuticals grimpe de 3% après des résultats supérieurs aux attentes

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Fennec Pharmaceuticals : résultats T4 2025 décevants

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Fennec Pharmaceuticals (NASDAQ:FENC)

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release